Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Merrimack Pharmaceuticals Inc logo

Merrimack Pharmaceuticals Inc

US$15.13

US$219.8m

0.07%

19.60%

Dashboard Funda..tals Deep..lue Prediction Screener Map

Merrimack Pharmaceuticals Inc Overview

Industry: Biotechnology

Sector: Healthcare

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Merrimack Pharmaceuticals Inc is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Merrimack Pharmaceuticals Inc in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Merrimack Pharmaceuticals Inc Competitors

Merrimack Pharmaceuticals Inc operates in the Biotechnology industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Merrimack Pharmaceuticals Inc

US$15.13

US$219.8m

0.07%

19.60%